Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Quinoline-based tetrazolium prochelators: formazan release, iron sequestration, and antiproliferative efficacy in
1Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ 85721-0041, USA. tomat@arizona.edu.
Abstract:
Iron-binding strategies in anticancer drug design target the key role of iron in cancer growth. The incorporation of a quinoline moiety in the design of tetrazolium-based prochelators facilitates their intracellular reduction/activation to iron-binding formazans. The new prochelators are antiproliferative at submicromolar levels, induce apoptosis and cell cycle arrest, and impact iron signaling in cancer cells.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

